Resumen
It has been hypothesized that enhancement of brain serotoninergic (5-HT) function is involved in the mechanism of action of some antidepressants. To test this, the prolactin response to intravenously administered tryptophan, a clinical measurement of 5-HT function, was assessed before and during antidepressant treatment. Depressed patients received the tricyclic desipramine hydrochloride (N = 24) or the 5-HT reuptake inhibitor fluvoxamine maleate (N = 30). The prolactin response was significantly enhanced after long-term treatment (4 weeks) but not as reliably increased after short-term (1-week) desipramine treatment. Fluvoxamine enhanced the prolactin response after both short- and long-term treatment. Enhancement of the prolactin response was not clearly correlated with clinical improvement. The results of this study are consistent with preclinical evidence of enhanced 5-HT function during treatment with these classes of antidepressants, but also indicate that enhanced 5-HT function is not a sufficient condition for antidepressant efficacy.
Idioma original | English (US) |
---|---|
Páginas (desde-hasta) | 625-631 |
Número de páginas | 7 |
Publicación | Archives of General Psychiatry |
Volumen | 46 |
N.º | 7 |
DOI | |
Estado | Published - jul 1989 |
ASJC Scopus subject areas
- Arts and Humanities (miscellaneous)
- Psychiatry and Mental health